Table 1
Western Europe N = 2845 | Eastern Europe N = 2171 | Latin America N = 795 | Asia N = 726 | North America N = 243 | Africa N = 79 | |
|---|---|---|---|---|---|---|
Median onset age, yrs | 4 | 6.3 | 6.6 | 5.9 | 7.5 | 5.7 |
Systemic arthritis, N (%) | 202 (7.1) | 165 (7.6) | 143 (18) | 174 (24) | 16 (4.9) | 11 (13.9) |
Oligoarthritis, N (%) | 1398 (49.1) | 958 (44.1) | 247 (31.1) | 256 (35.3) | 103 (31.8) | 25 (31.6) |
Enthesitis related arthritis, N (%) | 253 (8.9) | 248 (11.4) | 74 (9.3) | 92 (12.7) | 35 (10.8) | 3 (3.8) |
Uveitis, N (%) | 495 (17.4) | 232 (10.7) | 51 (6.4) | 40 (5.5) | 38 (11.7) | 4 (5.1) |
Median disease activity (JADAS10) | 2 | 5 | 3.5 | 3.5 | 2 | 5 |
Inactive disease, N (%) | 1070 (37.6) | 454 (20.9) | 268 (33.7) | 237 (32.6) | 114 (35.2) | 13 (16.5) |
Articular damage (JADI) > 0, N (%) | 352 (12.4) | 531 (24.5) | 257 (32.3) | 136 (18.7) | 60 (18.5) | 27 (34.2) |
Treated with biologics, N (%) | 1067 (37.5) | 637 (29.3) | 273 (34.3) | 134 (18.5) | 178 (54.9) | 27 (34.2) |